Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes
暂无分享,去创建一个
R P Johnson | B. Walker | O. Yang | S. Kalams | N. Jones | A. Trocha | R. Johnson | M. Rosenzweig | M Rosenzweig | O O Yang | S A Kalams | A Trocha | N Jones | M Koziel | B D Walker | M. Koziel | Spyros A. Kalams | R. Johnson
[1] F. Lemonnier,et al. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.
[2] Stefan Imreh,et al. Inhibition of antigen processing by the internal repeat region of the EpsteinBarr virus nuclear antigen-1 , 1995, Nature.
[3] T. Braciale,et al. Why can't cytotoxic T cells handle HIV? , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. A. Peterson,et al. A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.
[5] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[6] R. Morgan,et al. Multiple CTL specificities against autologous HIV-1-infected BLCLs. , 1995, Cellular immunology.
[7] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[8] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[9] R. Koup. Virus escape from CTL recognition , 1994, The Journal of experimental medicine.
[10] P. Greenberg,et al. Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1 , 1994, Journal of virology.
[11] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[12] R. Siliciano,et al. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine , 1994, Journal of virology.
[13] B. Walker,et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.
[14] D. Ho,et al. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope , 1994, The Journal of experimental medicine.
[15] R. F. Smith,et al. Human Retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences: I--II; III--V , 1993 .
[16] H. Ploegh,et al. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. , 1993, Journal of immunology.
[17] D. Singer,et al. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. , 1993, Science.
[18] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[19] Anthony S. Fauci,et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.
[20] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.
[21] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[22] John W. Mellors,et al. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .
[23] A. Hughes,et al. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. , 1992, Journal of immunology.
[24] B. Walker,et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.
[25] L. Gooding. Virus proteins that counteract host immune defenses , 1992, Cell.
[26] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[27] A. Meyerhans,et al. In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity , 1991, European journal of immunology.
[28] B. Walker,et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. , 1991, Journal of immunology.
[29] B. Moss,et al. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. , 1990, Journal of immunology.
[30] R. Young,et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Wecker,et al. Downregulation of HLA class I antigens in HIV-1-infected cells. , 1989, AIDS research and human retroviruses.
[32] J. Scheppler,et al. Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. , 1989, Journal of immunology.
[33] W. Wold,et al. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. , 1989, Molecular biology & medicine.
[34] R. Koup,et al. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. , 1989, Blood.
[35] B. Coupar,et al. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.
[36] B. Walker,et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.
[37] H. Varmus,et al. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression , 1988, Nature.
[38] R. Colvin,et al. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. , 1987, Journal of immunology.
[39] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[40] B. Coupar,et al. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response , 1986, European journal of immunology.